BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14517163)

  • 1. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
    Festa A; Hanley AJ; Tracy RP; D'Agostino R; Haffner SM
    Circulation; 2003 Oct; 108(15):1822-30. PubMed ID: 14517163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
    Festa A; D'Agostino R; Tracy RP; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, inflammation, and the prediabetic state.
    Haffner SM
    Am J Cardiol; 2003 Aug; 92(4A):18J-26J. PubMed ID: 12957323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.
    Haffner SM; Mykkänen L; Festa A; Burke JP; Stern MP
    Circulation; 2000 Mar; 101(9):975-80. PubMed ID: 10704163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
    Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Festa A; Goodarzi MO; Stefanovski D; Olson NC; Norris JM; Rewers MJ; Hanley AJ
    Diabetologia; 2013 Jan; 56(1):112-20. PubMed ID: 23052060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of body fat mass and distribution to markers of chronic inflammation.
    Festa A; D'Agostino R; Williams K; Karter AJ; Mayer-Davis EJ; Tracy RP; Haffner SM
    Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1407-15. PubMed ID: 11673759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
    Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
    Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
    Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction.
    Spadaro L; Alagona C; Palermo F; Piro S; Calanna S; Parrinello G; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):206-12. PubMed ID: 20096546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
    Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
    Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
    Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; D'Agostino R; Mykkänen L; Tracy R; Howard B; Rewers M; Selby J; Savage PJ; Saad MF
    Diabetes Care; 1999 Apr; 22(4):562-8. PubMed ID: 10189532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women.
    Fagerberg B; Kellis D; Bergström G; Behre CJ
    J Intern Med; 2011 Jun; 269(6):636-43. PubMed ID: 21198995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes.
    Temelkova-Kurktschiev T; Siegert G; Bergmann S; Henkel E; Koehler C; Jaross W; Hanefeld M
    Metabolism; 2002 Jun; 51(6):743-9. PubMed ID: 12037728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
    Festa A; D'Agostino R; Mykkänen L; Tracy RP; Zaccaro DJ; Hales CN; Haffner SM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):562-8. PubMed ID: 10073958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
    Hanley AJ; D'Agostino R; Wagenknecht LE; Saad MF; Savage PJ; Bergman R; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1263-70. PubMed ID: 11916954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contributions of insulin resistance and β-cell dysfunction to the development of Type 2 diabetes in Koreans.
    Kim CH; Kim HK; Kim EH; Bae SJ; Park JY
    Diabet Med; 2013 Sep; 30(9):1075-9. PubMed ID: 23600561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.